Literature DB >> 21751142

Up-regulated expression of Ezrin and c-Met proteins are related to the metastasis and prognosis of gastric carcinomas.

Jing Zhao1, Xiaoxiao Zhang, Yan Xin.   

Abstract

Recent publications demonstrated that abnormal expression of Ezrin and c-Met proteins were related to carcinogenesis, metastasis and prognosis of various sorts of tumors. In this study we detected the expressions of Ezrin and c-Met proteins in normal gastric mucosa, chronic atrophic gastritis, intestinal metaplasia, dysplasia and gastric carcinoma and analyzed the correlations with metastasis and prognosis of gastric carcinomas. The results demonstrated that both Ezrin and c-Met overexpression were related to the occurrence and progression of gastric carcinoma. Our findings also demonstrated that combined detection of these two tumor-specific biomarkers in gastric carcinomas can provide additional efficacy in predicting the patients' outcomes.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21751142     DOI： 10.14670/HH-26.1111

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN： 0213-3911            Impact factor:   2.303


  27 in total

Review 1.  Update on Gastroesophageal Adenocarcinoma Targeted Therapies.

Authors:  Steven B Maron; Daniel V T Catenacci
Journal:  Hematol Oncol Clin North Am       Date:  2017-06       Impact factor: 3.722

Review 2.  Novel Targeted Therapies for Esophagogastric Cancer.

Authors:  Steven B Maron; Daniel V T Catenacci
Journal:  Surg Oncol Clin N Am       Date:  2017-04       Impact factor: 3.495

Review 3.  Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges.

Authors:  Conor A Bradley; Manuel Salto-Tellez; Pierre Laurent-Puig; Alberto Bardelli; Christian Rolfo; Josep Tabernero; Hajrah A Khawaja; Mark Lawler; Patrick G Johnston; Sandra Van Schaeybroeck
Journal:  Nat Rev Clin Oncol       Date:  2017-04-04       Impact factor: 66.675

Review 4.  Clinical management of advanced gastric cancer: the role of new molecular drugs.

Authors:  Ferdinando De Vita; Natale Di Martino; Alessio Fabozzi; Maria Maddalena Laterza; Jole Ventriglia; Beatrice Savastano; Angelica Petrillo; Valentina Gambardella; Vincenzo Sforza; Luigi Marano; Annamaria Auricchio; Gennaro Galizia; Fortunato Ciardiello; Michele Orditura
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

5.  MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.

Authors:  Dong-Mei Li; Jun Zhang; Wen-Mei Li; Jian-Tao Cui; Yuan-Ming Pan; Si-Qi Liu; Rui Xing; You-Yong Lu
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

Review 6.  Clinical significance of MET in gastric cancer.

Authors:  Mikito Inokuchi; Sho Otsuki; Yoshitaka Fujimori; Yuya Sato; Masatoshi Nakagawa; Kazuyuki Kojima
Journal:  World J Gastrointest Oncol       Date:  2015-11-15

7.  Ezrin silencing remodulates the expression of Phosphoinositide-specific Phospholipase C enzymes in human osteosarcoma cell lines.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca
Journal:  J Cell Commun Signal       Date:  2014-07-30       Impact factor: 5.782

8.  Ezrin expression and its phosphorylation in gastric carcinoma with lymphoid stroma and Epstein-Barr virus infection.

Authors:  Taro Tobo; Minako Hirahashi; Takashi Yao; Shinichi Aishima; Yoshinao Oda
Journal:  Mol Clin Oncol       Date:  2012-12-28

Review 9.  Novel targeted agents for gastric cancer.

Authors:  Lian Liu; Ning Wu; Jin Li
Journal:  J Hematol Oncol       Date:  2012-06-18       Impact factor: 17.388

10.  The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays.

Authors:  Kambiz Sotoudeh; Forough Hashemi; Zahra Madjd; Alireza Sadeghipour; Saadat Molanaei; Elham Kalantary
Journal:  Diagn Pathol       Date:  2012-05-28       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.